Literature DB >> 11516700

[(11)]Cocaine: PET studies of cocaine pharmacokinetics, dopamine transporter availability and dopamine transporter occupancy.

J S Fowler1, N D Volkow, G J Wang, S J Gatley, J Logan.   

Abstract

Cocaine was initially labeled with carbon-11 in order to track the distribution and pharmacokinetics of this powerful stimulant and drug of abuse in the human brain and body. It was soon discovered that [(11)C]cocaine was not only useful for measuring cocaine pharmacokinetics and its relationship to behavior but that it is also a sensitive radiotracer for dopamine transporter (DAT) availability. Measures of DAT availability were facilitated by the development of a graphical analysis method (Logan Plot) for reversible systems which streamlined kinetic analysis. This expanded the applications of [(11)C]cocaine to studies of DAT availability in the human brain and allowed the first comparative measures of the degree of DAT occupancy by cocaine and another stimulant drug methylphenidate. This article will summarize preclinical and clinical research with [(11)C]cocaine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11516700     DOI: 10.1016/s0969-8051(01)00211-6

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  23 in total

Review 1.  Brain dopaminergic system changes in drug addiction: a review of positron emission tomography findings.

Authors:  Haifeng Hou; Chunyan Wang; Shaowei Jia; Shu Hu; Mei Tian
Journal:  Neurosci Bull       Date:  2014-09-28       Impact factor: 5.203

Review 2.  Nuclear Imaging in the Diagnosis of Clinically Uncertain Parkinsonian Syndromes.

Authors:  Ralph Buchert; Carsten Buhmann; Ivayla Apostolova; Philipp T Meyer; Jürgen Gallinat
Journal:  Dtsch Arztebl Int       Date:  2019-11-01       Impact factor: 5.594

Review 3.  DARK Classics in Chemical Neuroscience: Cocaine.

Authors:  Lindsey R Drake; Peter J H Scott
Journal:  ACS Chem Neurosci       Date:  2018-04-24       Impact factor: 4.418

Review 4.  CNS metabolism in high-risk drug abuse : Insights gained from 1H-, 31P-MRS and PET.

Authors:  S Bodea
Journal:  Radiologe       Date:  2018-11       Impact factor: 0.635

5.  Radiosynthesis and validation of ¹⁸F-FP-CMT, a phenyltropane with superior properties for imaging the dopamine transporter in living brain.

Authors:  Paul Cumming; Simone Maschauer; Patrick J Riss; Nuska Tschammer; Stefanie K Fehler; Markus R Heinrich; Torsten Kuwert; Olaf Prante
Journal:  J Cereb Blood Flow Metab       Date:  2014-04-09       Impact factor: 6.200

Review 6.  Cerebrovascular and cardiovascular diseases caused by drugs of abuse.

Authors:  Yuichi Akasaki; Mitsuru Ohishi
Journal:  Hypertens Res       Date:  2019-12-05       Impact factor: 3.872

7.  Methylation of the dopamine transporter gene in blood is associated with striatal dopamine transporter availability in ADHD: A preliminary study.

Authors:  Corinde E Wiers; Falk W Lohoff; Jisoo Lee; Christine Muench; Clara Freeman; Amna Zehra; Stefano Marenco; Barbara K Lipska; Pavan K Auluck; Ningping Feng; Hui Sun; David Goldman; James M Swanson; Gene-Jack Wang; Nora D Volkow
Journal:  Eur J Neurosci       Date:  2018-08       Impact factor: 3.386

Review 8.  [CNS metabolism in high-risk drug abuse, German version : Insights gained from 1H- and 31P MRS and PET].

Authors:  S V Bodea
Journal:  Radiologe       Date:  2017-06       Impact factor: 0.635

9.  Dopamine Regulation of Lateral Inhibition between Striatal Neurons Gates the Stimulant Actions of Cocaine.

Authors:  Lauren K Dobbs; Alanna R Kaplan; Julia C Lemos; Aya Matsui; Marcelo Rubinstein; Veronica A Alvarez
Journal:  Neuron       Date:  2016-05-12       Impact factor: 17.173

10.  D2R DNA transfer into the nucleus accumbens attenuates cocaine self-administration in rats.

Authors:  Panayotis K Thanos; Michael Michaelides; Hiroyuki Umegaki; Nora D Volkow
Journal:  Synapse       Date:  2008-07       Impact factor: 2.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.